Paul Verbraeken
Analyst-Equity bij Research Partners AG
Profiel
Mr. Paul Verbraeken is a Senior Analyst at Research Partners AG.
He has more than 25 years of experience as an IR Manager, including as Head of IR at a healthcare company listed on SIX Swiss Exchanges, and as an equity analyst at a number of European investment banks.
He holds a degree in Auditing from The Hague University of Applied Sciences (Netherlands) and has received further training in investor relations from the Amsterdam Institute of Finance/INSEAD and the Investor Relations Society, London.
Actieve functies van Paul Verbraeken
Bedrijven | Functie | Begin |
---|---|---|
Research Partners AG
Research Partners AG Investment ManagersFinance Research Partners AG provides investment research. The private company is based in Zurich, Switzerland. The Swiss company was founded in 2014 by Martin Coninx. Martin Coninx has been the CEO since 2014. | Analyst-Equity | 01-10-2018 |
Eerdere bekende functies van Paul Verbraeken
Bedrijven | Functie | Einde |
---|---|---|
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Public Communications Contact | 14-12-2009 |
HSBC Bank Plc (Broker)
HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Analyst-Equity | 09-04-2002 |
EVOLVA HOLDING SA | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
EVOLVA HOLDING SA | Consumer Non-Durables |
Bedrijven in privébezit | 3 |
---|---|
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
HSBC Bank Plc (Broker)
HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Finance |
Research Partners AG
Research Partners AG Investment ManagersFinance Research Partners AG provides investment research. The private company is based in Zurich, Switzerland. The Swiss company was founded in 2014 by Martin Coninx. Martin Coninx has been the CEO since 2014. | Finance |